rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-16
|
pubmed:databankReference |
|
pubmed:abstractText |
The efficacy of galantamine has been shown in patients with mild, moderate, and advanced moderate Alzheimer's disease (AD). Here we report its efficacy in patients with severe AD.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1474-4422
|
pubmed:author |
pubmed-author:BernabeiRobertoR,
pubmed-author:BullockRogerR,
pubmed-author:BurnsAlistairA,
pubmed-author:CameElizabethE,
pubmed-author:Cruz JentoftAlfonso JAJ,
pubmed-author:FrölichLutzL,
pubmed-author:HammondGerry LGL,
pubmed-author:HockChristophC,
pubmed-author:RaivioMinnaM,
pubmed-author:SchwalenSusanneS,
pubmed-author:TriauEricE,
pubmed-author:Van BaelenBartB,
pubmed-author:VandewoudeMauritsM,
pubmed-author:WimoAndersA,
pubmed-author:van OeneJoop CJC
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-47
|
pubmed:dateRevised |
2009-2-11
|
pubmed:meshHeading |
pubmed-meshheading:19042161-Activities of Daily Living,
pubmed-meshheading:19042161-Aged, 80 and over,
pubmed-meshheading:19042161-Alzheimer Disease,
pubmed-meshheading:19042161-Cognition,
pubmed-meshheading:19042161-Double-Blind Method,
pubmed-meshheading:19042161-Electrocardiography,
pubmed-meshheading:19042161-Female,
pubmed-meshheading:19042161-Galantamine,
pubmed-meshheading:19042161-Humans,
pubmed-meshheading:19042161-Male,
pubmed-meshheading:19042161-Neuropsychological Tests,
pubmed-meshheading:19042161-Nootropic Agents
|
pubmed:year |
2009
|
pubmed:articleTitle |
Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.
|
pubmed:affiliation |
University of Manchester, Manchester, UK. alistair.burns@manchester.ac.uk
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|